OneMedNet CEO Aaron Green Buys Shares of ONMD
Aaron Green, CEO of OneMedNet, purchased 18,702 shares, signaling confidence in the company.
Key Points
- Aaron Green, CEO of OneMedNet, purchased 18,702 shares at $0.54 each, totaling $10,099.08 on June 15, 2026.
- Shares of OneMedNet (NasdaqCM:ONMD) traded around $0.54 with a market cap of approximately $30.37 million.
- Other funds like Exencial Wealth Advisors and Vanguard Capital Management have also increased their positions in OneMedNet.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 15, 2026, Aaron Green, the Chief Executive Officer of OneMedNet Corporation, bought 18,702 shares of the company at an average price of $0.54 per share. This purchase totaled $10,099.08 and was not part of a pre-arranged trading plan.
Insider Buying and Selling at OneMedNet Corporation
Aaron Green's recent purchase isn't his only one this month. On June 12, he acquired 36,920 shares at $0.56 each. Another insider, Thomas Kosasa, bought 158,730 shares at $0.63 on June 12 and 268,817 shares at $0.93 on May 18. Earlier, Jeffrey Yu, the Chief Medical Officer, purchased 219,429 shares at $0.83 on April 1.
Other Institutional Activity in OneMedNet
Several institutional investors have shown interest in OneMedNet recently. Exencial Wealth Advisors increased its holdings by 4,732,698 shares, reaching 8,377,559 shares valued at about $7.12 million. Vanguard Capital Management added 1,115,565 shares, bringing its total to the same number, worth approximately $948,230. Geode Capital Management also expanded its stake by 41,802 shares, ending with 338,528 shares valued at $287,782.
OneMedNet Corporation Stock Down 13.6%
Shares of OneMedNet (NasdaqCM:ONMD) were trading near $0.54. The company has a market cap of approximately $30.37 million and a beta of 1.122, indicating moderate volatility. Over the past year, the stock has traded between $0.33 and $4.22. The 50-day moving average is $0.87, while the 200-day moving average is $1.15.
$ONMD stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
OneMedNet reported revenue of $1.32 million, showing a decline of 29.9% compared to the previous period. The company is not currently profitable, with a net margin of -254.3%. Earnings per share were negative at -$0.04.
About OneMedNet Corporation
OneMedNet Corporation, based in Eden Prairie, Minnesota, is a healthcare software company. It specializes in digital medical image management, exchange, and sharing solutions across the Americas, Europe, and the Middle East. The company's flagship products include iRWD, which offers regulatory-grade imaging and clinical data for various markets, and BEAM, a platform for exchanging medical images among healthcare providers and patients. Led by CEO Aaron Green, OneMedNet employs 22 people.
Bottom Line
Aaron Green's recent share purchase reflects a vote of confidence in OneMedNet Corporation, aligning with other institutional investors who have increased their positions. As a healthcare software company, OneMedNet is navigating a challenging market with a focus on digital medical image management. Investors will be watching closely to see if the CEO's optimism is shared by the market.
Get OneMedNet Corporation alerts
New 13F filings, insider trades, and analyst moves on $ONMD, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.